Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 4/20 | 0.49 |
| ▸ | CALCRL | Q16602 | 4/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | REN | P00797 | 3/20 | 0.41 |
| ▸ | ACE | P12821 | 3/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
| ▸ | F2R | P25116 | 2/20 | 0.40 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.40 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29434627 | 0.89 | CAPN1 (0.51) | CAPN1SLC6A2RENACECTSB | |
| SCHEMBL30123074 | 0.86 | ACE (0.47) | CAPN1RENACEF2R | |
| SCHEMBL29587503 | 0.86 | CALCRL (0.58) | CALCRLSLC6A2RENACE | |
| SCHEMBL29666768 | 0.86 | ACE (0.46) | RENACE | |
| SCHEMBL30272477 | 0.85 | ACE (0.47) | CAPN1RENACEF2R | |
| SCHEMBL30997445 | 0.84 | CAPN1 (0.48) | CAPN1CALCRLSLC6A2RENACE | |
| SCHEMBL30407242 | 0.84 | CAPN1 (0.49) | CAPN1CALCRLRENACECTSB | |
| SCHEMBL29654687 | 0.84 | CALCRL (0.40) | CAPN1CALCRLSLC6A2RENACE | |
| SCHEMBL30165187 | 0.83 | F2R (0.47) | CAPN1RENACEF2R | |
| SCHEMBL9471485 | 0.83 | ACE (0.48) | RENACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025202114-A1 | RADIOSENSITISING PEPTIDE COMPLEX | GCS INSTITUT DE CANCEROLOGIE STRASBOURG EUROPE (FR) | 2025-10-02 | — | — | WO | disclosed |